Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled, “Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial,” which published online December 30, 2020, and in print in the February 2021 issue,1 the trial registration information was incorrect. The correct ClinicalTrials.gov identifier is NCT04439123. This article was corrected online.
Error in the Abstract. JAMA Oncol. 2021;7(11):1729. doi:10.1001/jamaoncol.2021.5290
Oncology in JAMA: Read the Latest